Rna Diagnostics Inc.
John Connolly has extensive experience in various leadership positions within the healthcare and biotechnology sectors. John currently serves as the Chief Executive Officer at Rna Diagnostics Inc., a company specializing in cancer treatment assessment. Prior to this, they held the role of Managing Director at York Medtech Partners from 2006 to 2010. Before joining York Medtech Partners, John was a Partner at Corporate Growth Strategies from 2001 to 2006. Additionally, they served as the Vice President of Corporate Development at Systems Xcellence Inc. from 1999 to 2001 and as the Vice President and Partner at MDS Capital Corp. from 1996 to 1999.
John Connolly earned a Bachelor of Arts degree in Economics and Philosophy from McGill University, where they studied from 1974 to 1977. John later pursued a Master of Business Administration (MBA) from the Ivey Business School at Western University, completing their studies from 1980 to 1982.
This person is not in any teams
This person is not in any offices
Rna Diagnostics Inc.
Rna Diagnostics is an early-stage molecular diagnostics company developing medical diagnostic tools to assist in the management of cancer. The company's first product, the RNA Disruption AssayTM (RDATM), is a novel test that helps oncologists rapidly assess the effectiveness of cancer chemotherapy.